Aptevo Therapeutics (APVO) Shares Outstanding (Entity) (2015 - 2026)
Aptevo Therapeutics' Shares Outstanding (Entity) came in at 1.42 million for Q2 2026, compared with 41,012 a year earlier and up 17.9% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Shares Outstanding (Entity) (2015 - 2026) Analysis & Trends
For FY2025, Aptevo Therapeutics' Shares Outstanding (Entity) was 315,535.
- Shares Outstanding (Entity) carries a five-year compound annual growth rate of 779.4% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 767.00 in FY2024, 21.00 in FY2023 (+133.3%), 9.00 in FY2022 (+12.5%) and 8.00 in FY2021 (+33.3%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q2 2015.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 12.5% in Q1 2022 to 325.0% in Q1 2024.
- Business Quant data shows APVO's Shares Outstanding (Entity) at 1.2 million (Q1 2026), 315,535 (Q4 2025) and 224,965 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Aptevo Therapeutics | 2.58 Mn | -64.42 Mn | - | 1.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.42 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 315,535.00 |
| Sep 30, 2025 | 224,965.00 |
| Jun 30, 2025 | 41,012.00 |
| Mar 31, 2025 | 4,052.00 |
| Dec 31, 2024 | 767.00 |
| Sep 30, 2024 | 792.00 |
| Jun 30, 2024 | 306.00 |
| Mar 31, 2024 | 51.00 |
| Dec 31, 2023 | 21.00 |
| Sep 30, 2023 | 25.00 |
| Jun 30, 2023 | 13.00 |
| Mar 31, 2023 | 12.00 |
| Dec 31, 2022 | 9.00 |
| Sep 30, 2022 | 9.00 |
| Jun 30, 2022 | 9.00 |
| Mar 31, 2022 | 9.00 |
| Dec 31, 2021 | 8.00 |
| Sep 30, 2021 | 8.00 |
API Access
Aptevo Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();